Stay updated on Stereotactic RT+Pembrolizumab in Oligometastatic Renal Cancer Clinical Trial

Sign up to get notified when there's something new on the Stereotactic RT+Pembrolizumab in Oligometastatic Renal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Stereotactic RT+Pembrolizumab in Oligometastatic Renal Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The Publications section now clarifies that PubMed-sourced publications are auto-filled and linked to the NCT number. It specifies the origin of these entries and how they relate to the study record.
    Difference
    0.1%
    Check dated 2025-11-25T13:35:37.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Removed the government funding lapse notice from the page, which previously stated that information may not be up to date and that the agency may not respond until appropriations are enacted. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T07:22:20.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    The Study Details page appears unchanged between the two screenshots; no new or removed information was detected.
    Difference
    0.5%
    Check dated 2025-11-03T21:26:13.000Z thumbnail image
  5. Check
    62 days ago
    Change Detected
    Summary
    Major update: announces a funding-related operating status notice and a new version v3.2.0; replaces the earlier v3.1.0 release.
    Difference
    3%
    Check dated 2025-10-06T07:00:57.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    Version update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.
    Difference
    0.1%
    Check dated 2025-09-29T03:49:29.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Updated from Revision: v3.0.1 to Revision: v3.0.2; the 'Back to Top' link was removed.
    Difference
    0.2%
    Check dated 2025-09-14T21:45:23.000Z thumbnail image

Stay in the know with updates to Stereotactic RT+Pembrolizumab in Oligometastatic Renal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Stereotactic RT+Pembrolizumab in Oligometastatic Renal Cancer Clinical Trial page.